Core Insights - Clover Health Investments, Corp. (CLOV) shares have decreased by 34% following disappointing Q3 earnings, primarily due to a significant increase in medical costs, prompting the company to reduce its guidance [1] Financial Performance - The Q3 earnings report revealed a major spike in medical costs for Clover Health, which has negatively impacted its financial outlook [1] Market Trends - The decline in CLOV shares reflects broader market reactions to disappointing earnings reports, particularly in the healthcare sector where rising costs are a concern [1]

Core Insights - Blue Bird Corporation (BLBD) reported strong Q4 earnings, with both top-line and bottom-line outperforming expectations, yet the stock price fell by 5.5% post-earnings release [1] Financial Performance - The Q4 earnings release showcased significant financial performance, indicating robust revenue and profit growth for Blue Bird Corporation [1] Market Reaction - Despite the positive earnings report, the market reacted negatively, leading to a notable decline in the stock price, suggesting potential investor concerns or market dynamics at play [1]